CVS Stock: CVS Health Corporation (NYSE:CVS) Is Still Worth a Bite
CVS Health Corporation (NYSE:CVS) has a beta of 0.81, a 12-month trailing P/E ratio of 15.20, and a growth ratio of 3.80. The stock’s Relative
CVS Health Corporation (NYSE:CVS) has a beta of 0.81, a 12-month trailing P/E ratio of 15.20, and a growth ratio of 3.80. The stock’s Relative
CVS Health Corporation (NYSE:CVS) Relative Strength Index (RSI) is 58.50, with weekly volatility at 1.30% and ATR at 1.60. The CVS stock’s 52-week price range
CVS Health Corporation (NYSE:CVS) previous close was $86.44 while the outstanding shares total 1.31B. The firm has a beta of 0.81, a 12-month trailing P/E
The U.S. furniture retail giant, The Home Depot Inc (HD) fell -2.54 percent, reported increased spending in the quarter ended, helping with 24 percent solid
Discover high-quality information at your convenience with ‘State Reviewer.’ Our news portal offers valuable insights for free, available in accessible locations such as metro stations, busy intersections, cafes, and business centers. Wherever your day takes you, ‘State Reviewer’ ensures you’re never out of touch with the latest news and updates.
All rights reserved © 2024, Powered by Smart TechOne